Study Reveals Importance Of Timing For Cellular Signals, Suggests Possible Tactic For Cancer Therapeutics
Magic tricks work because they take advantage of the brain’s sensory assumptions, tricking audiences into seeing phantoms or overlooking sleights of hand. Now a team of UC San Francisco researchers has discovered that even brainless single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.
“The ability to perceive and respond to the environment is a basic attribute of all living organisms, from the greatest to the smallest,” said Wendell Lim, PhD, the study’s senior author. “And so is the susceptibility to misperception. It doesn’t matter if the illusion is based on molecular sensors within a single cell or neurons in the brain.”
In the new study, published online Nov. 19, 2015 in Science Express, Lim and his team discovered that yeast cells falsely perceive a specifically timed pattern of stress – caused by alternating between low and mildly increased sodium levels – as a massive, continuously increasing ramp of stress. In response, the microbes end up over-responding and killing themselves. The results, Lim says, suggest a whole new way of looking at the perceptual abilities of simple cells and could even be used to develop new approaches to fighting diseases using the power of illusion.
Timing of stress response is yeast cells’ ‘Achilles heel’
“This discovery was a bit of an accident actually,” said Lim, chair of the Department of Cellular and Molecular Pharmacology at UCSF, director of the UCSF Center for Systems and Synthetic Biology, and a Howard Hughes Medical Institute (HHMI) investigator. “We were interested in the general issue of how cells interpret information over time. Frequency is a key aspect of all our communications, whether it’s hearing language or transmitting radio signals, but do cells themselves use this kind of information? It’s something we don’t know much about.”
To explore this question, two postdoctoral fellows in Lim’s lab, Ping Wei, PhD, now at Peking University School of Life Sciences, and Amir Mitchell, PhD, set up a system that allowed them to expose yeast to a mild stressor – a small increase in salt in the yeast’s environment – and to oscillate between the increased salt level and the baseline level at different frequencies.
Normally, sensor molecules in a yeast cell detect changes in salt concentration and instruct the cell to respond by producing a protective chemical. After this transient response, the cell can resume growing happily as if conditions had not changed. The researchers found that the cells were perfectly capable of adapting when they flipped the salt stress on and off every minute or every 32 minutes. But to their surprise, when they tried an eight-minute oscillation of precisely the same salt level the cells quickly stopped growing and began to die off.
“That was just a jaw-dropping moment,” said Mitchell. “These cells should be able to handle this level of osmotic stress, but at one particular frequency they just go haywire. We’d never seen anything like this before.”
Could sensory illusions be used to fight cancer?
Mitchell, who was first author on the new study, went on to inspect the cellular mechanism underlying this unexpected, frequency-dependent toxicity. Using mathematical modeling and experiments in which he tweaked the molecular wiring of the mitogen activated protein kinase (MAPK) pathway that mediates the cells’ salt-sensing system, he revealed a sensory misperception: Because of the way the MAPK pathway is set up, the cells interpret an eight-minute oscillation as an ever-increasing staircase of salt concentration. This leads to excessive activation of the cells’ protective response, and ultimately to their death (see Movie).
Read more: Sensory Illusion Causes Cells to Self-Destruct
The Latest News on: Cancer Therapeutics
Global Cancer Therapeutics Market to 2023 with Patents and Expiry Dates for Major Products by Leading Suppliers - GlobeNewswire
February 5, 2019 - Global Cancer Therapeutics Market to 2023 with Patents and Expiry Dates for Major Products by Leading Suppliers GlobeNewswireDublin, Feb. 05, 2019 (GLOBE NEWSWIRE) -- The "Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions" report has been ...
Cancer Therapeutics Market to Accrue $178.86 Bn, Globally, by 2023 at 11.9% CAGR, Says AMR - PRNewswire
January 31, 2019 - Cancer Therapeutics Market to Accrue $178.86 Bn, Globally, by 2023 at 11.9% CAGR, Says AMR PRNewswirePORTLAND, Oregon, January 31, 2019 /PRNewswire/ -- High prevalence of cancer, surge in R&D for novel treatment modalities, and increase in healthcare...
Peptide Based Cancer Therapeutics Market are estimated to surpass Robust CAGR Forecast Years 2022 - Honest Version
February 8, 2019 - Peptide Based Cancer Therapeutics Market are estimated to surpass Robust CAGR Forecast Years 2022 Honest VersionMedical research institutes as well as investors in the global pharmaceuticals sector are ramping up their efforts toward development of profound therapeutic ...
Two singular men shared an uncommon greatness: Waun Ki Hong and John Mendelsohn - The Cancer Letter Publications
February 8, 2019 - Two singular men shared an uncommon greatness: Waun Ki Hong and John Mendelsohn The Cancer Letter PublicationsDirector, Moores Cancer Center, associate vice chancellor, and Chugai Pharmaceutical Chair, UC San Diego; adjunct professor and former chief of the Section ...
Global Breast Cancer Therapeutics Market 2019 Growth Analysis, Opportunities, Revenue and sales, Trends and Developments, Forecast by 2023 - Slap Coffee
February 8, 2019 - Global Breast Cancer Therapeutics Market 2019 Growth Analysis, Opportunities, Revenue and sales, Trends and Developments, Forecast by 2023 Slap CoffeeThe latest report titled Breast Cancer Therapeutics Market has the simplest recommendation on the topic of the great Breast Cancer Therapeutics market.
Cancer biotech Harpoon Therapeutics prices $76 million IPO at $14 midpoint - Nasdaq
February 7, 2019 - Cancer biotech Harpoon Therapeutics prices $76 million IPO at $14 midpoint NasdaqHarpoon Therapeutics, a Phase 1 biotech developing T cell immunotherapies for various cancers, raised $76 million by offering 5.4 million shares at $14, the ...
National Foundation for Cancer Research Announces Leadership Transition - Markets Insider
February 7, 2019 - National Foundation for Cancer Research Announces Leadership Transition Markets InsiderROCKVILLE, Md., Feb. 08, 2019 /PRNewswire-PRWeb/ -- The National Foundation for Cancer Research (NFCR) today announced the promotion of Sujuan Ba, ...
Human Papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2019 - ResearchAndMarkets.com - Odessa American
February 8, 2019 - Human Papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2019 - ResearchAndMarkets.com Odessa AmericanDUBLIN--(BUSINESS WIRE)--Feb 8, 2019--The "Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2019" drug pipelines has been added to ...
Personalized context of the cancer cell - Healio
February 8, 2019 - Personalized context of the cancer cell HealioHemonc Today | For decades, prognostic markers and therapeutics have been focused largely on the cancer cell's growth patterns in tissue culture or in animal ...
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 – Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence - Honest Version
February 6, 2019 - Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 – Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence Honest VersionResearchmoz added latest report “Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 – Growth Driven by Increasing Uptake of Targeted Therapies and ...